335 related articles for article (PubMed ID: 30374165)
1. Identification of a cellularly active SIRT6 allosteric activator.
Huang Z; Zhao J; Deng W; Chen Y; Shang J; Song K; Zhang L; Wang C; Lu S; Yang X; He B; Min J; Hu H; Tan M; Xu J; Zhang Q; Zhong J; Sun X; Mao Z; Lin H; Xiao M; Chin YE; Jiang H; Xu Y; Chen G; Zhang J
Nat Chem Biol; 2018 Dec; 14(12):1118-1126. PubMed ID: 30374165
[TBL] [Abstract][Full Text] [Related]
2. MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer.
Shang JL; Ning SB; Chen YY; Chen TX; Zhang J
Acta Pharmacol Sin; 2021 Jan; 42(1):120-131. PubMed ID: 32541922
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D
Shang J; Zhu Z; Chen Y; Song J; Huang Y; Song K; Zhong J; Xu X; Wei J; Wang C; Cui L; Liu CY; Zhang J
Theranostics; 2020; 10(13):5845-5864. PubMed ID: 32483423
[TBL] [Abstract][Full Text] [Related]
4. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin 6 promotes transforming growth factor-β1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence.
Feng XX; Luo J; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Feng ZH; Tian DA
Cancer Sci; 2015 May; 106(5):559-66. PubMed ID: 25683165
[TBL] [Abstract][Full Text] [Related]
6. Deacetylation of Ku70 by SIRT6 attenuates Bax-mediated apoptosis in hepatocellular carcinoma.
Tao NN; Ren JH; Tang H; Ran LK; Zhou HZ; Liu B; Huang AL; Chen J
Biochem Biophys Res Commun; 2017 Apr; 485(4):713-719. PubMed ID: 28238784
[TBL] [Abstract][Full Text] [Related]
7. Sirt6 suppresses hepatocellular carcinoma cell growth via inhibiting the extracellular signal‑regulated kinase signaling pathway.
Zhang ZG; Qin CY
Mol Med Rep; 2014 Mar; 9(3):882-8. PubMed ID: 24366394
[TBL] [Abstract][Full Text] [Related]
8. The SIRT6 activator MDL-800 improves genomic stability and pluripotency of old murine-derived iPS cells.
Chen Y; Chen J; Sun X; Yu J; Qian Z; Wu L; Xu X; Wan X; Jiang Y; Zhang J; Gao S; Mao Z
Aging Cell; 2020 Aug; 19(8):e13185. PubMed ID: 33089974
[TBL] [Abstract][Full Text] [Related]
9. SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
Kohli S; Bhardwaj A; Kumari R; Das S
Cancer Res; 2018 Feb; 78(3):645-658. PubMed ID: 29217762
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of activation for the sirtuin 6 protein deacylase.
Klein MA; Liu C; Kuznetsov VI; Feltenberger JB; Tang W; Denu JM
J Biol Chem; 2020 Jan; 295(5):1385-1399. PubMed ID: 31822559
[TBL] [Abstract][Full Text] [Related]
11. NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma.
Zhou HZ; Zeng HQ; Yuan D; Ren JH; Cheng ST; Yu HB; Ren F; Wang Q; Qin YP; Huang AL; Chen J
Cell Commun Signal; 2019 Dec; 17(1):168. PubMed ID: 31842909
[TBL] [Abstract][Full Text] [Related]
12. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
Han LL; Jia L; Wu F; Huang C
Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
[TBL] [Abstract][Full Text] [Related]
13. Screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cells.
Tenhunen J; Kučera T; Huovinen M; Küblbeck J; Bisenieks E; Vigante B; Ogle Z; Duburs G; Doležal M; Moaddel R; Lahtela-Kakkonen M; Rahnasto-Rilla M
Biomed Pharmacother; 2021 Jun; 138():111452. PubMed ID: 33684691
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the Allosteric Activation Mechanism of SIRT6 Using Molecular Dynamics Simulations.
Zhao Z; Du J; Du Y; Gao Y; Yu M; Zhang Y; Fang H; Hou X
J Chem Inf Model; 2023 Sep; 63(18):5896-5902. PubMed ID: 37653718
[TBL] [Abstract][Full Text] [Related]
15. Identification of and Molecular Basis for SIRT6 Loss-of-Function Point Mutations in Cancer.
Kugel S; Feldman JL; Klein MA; Silberman DM; Sebastián C; Mermel C; Dobersch S; Clark AR; Getz G; Denu JM; Mostoslavsky R
Cell Rep; 2015 Oct; 13(3):479-488. PubMed ID: 26456828
[TBL] [Abstract][Full Text] [Related]
16. SIRT6 regulates the proliferation and apoptosis of hepatocellular carcinoma via the ERK1/2 signaling pathway.
Zhang C; Yu Y; Huang Q; Tang K
Mol Med Rep; 2019 Aug; 20(2):1575-1582. PubMed ID: 31257493
[TBL] [Abstract][Full Text] [Related]
17. SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice.
Qin K; Zhang N; Zhang Z; Nipper M; Zhu Z; Leighton J; Xu K; Musi N; Wang P
Diabetologia; 2018 Apr; 61(4):906-918. PubMed ID: 29322219
[TBL] [Abstract][Full Text] [Related]
18. Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6.
Wood M; Rymarchyk S; Zheng S; Cen Y
Arch Biochem Biophys; 2018 Jan; 638():8-17. PubMed ID: 29233643
[TBL] [Abstract][Full Text] [Related]
19. SIRT6 Depletion Suppresses Tumor Growth by Promoting Cellular Senescence Induced by DNA Damage in HCC.
Lee N; Ryu HG; Kwon JH; Kim DK; Kim SR; Wang HJ; Kim KT; Choi KY
PLoS One; 2016; 11(11):e0165835. PubMed ID: 27824900
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity.
Chen X; Sun W; Huang S; Zhang H; Lin G; Li H; Qiao J; Li L; Yang S
J Med Chem; 2020 Sep; 63(18):10474-10495. PubMed ID: 32787077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
